Skip to content
Search

Latest Stories

DHSC implements process to roll over eligible price concessions from May

Department of Health and Social Care (DHSC) has implemented a process to roll over certain concessionary prices to the following month.

From May 2023, the roll over process will apply to any products where agreement is reached on the final prices granted by DHSC for any price concession requests submitted late in the month (on or after the 23rd of the month) by Community Pharmacy England.


Community Pharmacy England said: "As part of the Year 4 & 5 funding settlement for community pharmacy, it was agreed that an urgent review of the price concession setting system would take place."

It has been working with DHSC to determine improvements to the price concession system.

The following price concessions granted in May 2023 have rolled over to June 2023:

DrugPack SizePrice concession
Chloramphenicol 0.5% eye drops10£9.68
Chlorphenamine 2mg/5ml oral solution sugar free150£3.04
Clotrimazole 500mg pessary and Clotrimazole 2% cream1£10.35
Lansoprazole 30mg orodispersible tablets28£5.52
Methylphenidate 10mg tablets30£3.08
Venlafaxine 150mg modified-release capsules28£4.98
Venlafaxine 150mg modified-release tablets30£4.85
Venlafaxine 75mg modified-release tablets30£2.95

Community Pharmacy England said: “Pharmacy owners (members) will be able to see the lines that have rolled over on our price concessions page here. Please note any rolled over prices can be adjusted upwards if we receive reports from our members to indicate suppliers’ selling prices have increased. The review can be requested at any point during the month.”

“One of the earlier changes agreed between Community Pharmacy England and DHSC was that all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession. From 1 April 2023, a new Group Items category has been added to Part II of the Drug Tariff for ‘Drugs for which discount is not deducted’.

A further solution recently announced by DHSC to help improve current the price concession system includes a ‘retrospective increased payment’ which may apply, when appropriate. We are continuing to seek further improvements to the price concession system.”

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less